Lots of parts moving and yet the stock is still only $1.56. The news to come on Kevetrin end of Phase 1 and more news re planned Phase 2 trials is very close. U of B news hopefully very soon. B-OM and Prurisol trial progression and the real news maker Brilacidin a new class of antibiotics entering Phase 3. The medical world is going to spread the word for us on that one for sure. All for $1.56. Nah not for long how about a return to previous highs?

Ps funny comment by TB on other board.